Trial · NCT01079949
Results by group56
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 56
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Oocytes Retrieved | r-hFSH + r-hLH | 10 | Standard Deviation 3.8 | oocytes | |
| Number of Oocytes Retrieved | r-hFSH | 10 | Standard Deviation 5.2 | oocytes | |
| Number of Mature Oocytes Retrieved | r-hFSH + r-hLH | Geminal vesicle (GV) | 60 | mature oocytes | |
| Number of Mature Oocytes Retrieved | r-hFSH | Geminal vesicle (GV) | 37 | mature oocytes | |
| Number of Mature Oocytes Retrieved | r-hFSH + r-hLH | Meta-I | 44 | mature oocytes | |
| Number of Mature Oocytes Retrieved | r-hFSH | Meta-I | 26 | mature oocytes | |
| Number of Mature Oocytes Retrieved | r-hFSH + r-hLH | Meta-II | 275 | mature oocytes | |
| Number of Mature Oocytes Retrieved | r-hFSH | Meta-II | 292 | mature oocytes | |
| Number of Mature Oocytes Retrieved | r-hFSH + r-hLH | Atresic | 10 | mature oocytes | |
| Number of Mature Oocytes Retrieved | r-hFSH | Atresic | 4 | mature oocytes | |
| Number of Participants With Ovarian Hyper Stimulation Syndrome (OHSS) | r-hFSH + r-hLH | 0 | participants | ||
| Number of Participants With Ovarian Hyper Stimulation Syndrome (OHSS) | r-hFSH | 0 | participants | ||
| Number of Cycles Cancelled Due to Risk of Ovarian Hyper Stimulation Syndrome (OHSS) | r-hFSH + r-hLH | 0 | cycles | ||
| Number of Cycles Cancelled Due to Risk of Ovarian Hyper Stimulation Syndrome (OHSS) | r-hFSH | 0 | cycles | ||
| Number of Participants With Adverse Events (AEs) | r-hFSH + r-hLH | 3 | participants | ||
| Number of Participants With Adverse Events (AEs) | r-hFSH | 0 | participants | ||
| Number of Follicles Greater Than or Equal to 14 Millimeter (mm) on Recombinant Human Choriogonadotropin (r-hCG) Day | r-hFSH + r-hLH | 8.6 | Standard Deviation 3.9 | follicles | |
| Number of Follicles Greater Than or Equal to 14 Millimeter (mm) on Recombinant Human Choriogonadotropin (r-hCG) Day | r-hFSH | 7.4 | Standard Deviation 3.9 | follicles | |
| Endometrial Thickness on Recombinant Human Choriogonadotropin (r-hCG) Day | r-hFSH + r-hLH | 9.5 | Standard Deviation 2.1 | mm | |
| Endometrial Thickness on Recombinant Human Choriogonadotropin (r-hCG) Day | r-hFSH | 8.8 | Standard Deviation 2.2 | mm |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01079949/results